z-logo
open-access-imgOpen Access
Semaglutide May Alleviate Hepatic Steatosis in T2DM Combined with NFALD Mice via miR-5120/ABHD6
Author(s) -
Ran Li,
Zhengqin Ye,
Dunmin She,
Ping Fang,
Guannan Zong,
Kerong Hu,
Dehong Kong,
Wei Xu,
Ling Li,
Yun Zhou,
KeQin Zhang,
Ying Xue
Publication year - 2022
Publication title -
drug design, development and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.964
H-Index - 64
ISSN - 1177-8881
DOI - 10.2147/dddt.s384884
Subject(s) - steatosis , semaglutide , fatty liver , medicine , endocrinology , biology , diabetes mellitus , type 2 diabetes , disease , liraglutide

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here